trial · primary record
KQB365
KRAS G12C Mutation
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 140 |
| Primary completion | 2030-06-30 |
| Primary endpoint | Number of patients who experience treatment-emergent adverse events, serious adverse events, and dose-limiting toxicities (Part 1) |
| Registry ID | NCT06720987 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:55:04.053Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06720987
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.